IDH1 and astrocytoma (excluding glioblastoma): Among LTS, 240/246 (97.6%) had IDH-mutant tumors of whom molecular reclassification showed a change of tumor type (such as astrocytoma to oligodendroglioma or vice versa) in 21 (8.8%) patients, while there were no changes in tumor grading.